Reference
Saudi Food and Drug Authority (SFDA). Safety signal of encorafenib and the risk of tumour lysis syndrome. Internet Document : 21 Nov 2023. Available from: URL: https://www.sfda.gov.sa/sites/default/files/2023-11/Encorafenib%20and%20Risk%20of%20Tumour%20lysis%20syndrome%20-%20Signal%20communication.pdf
Rights and permissions
About this article
Cite this article
Encorafenib: risk of tumour lysis syndrome. Reactions Weekly 1986, 1 (2023). https://doi.org/10.1007/s40278-023-51306-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-51306-9